Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 to 75

Evaluating the effects of beta blockers on outcomes in traumatic brain injury patients

Official title: Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury

Run by Mansoura University · NCT06836856 · Data updated 2026-11-12

This study is testing whether beta blockers can help improve recovery for people with moderate to severe traumatic brain injuries.

More TBI (Traumatic Brain Injury) trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment100 (estimated)
SponsorMansoura University
Academic / other
Locations2 sites (Zagazig and 1 other locations)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedJune 2025
Study endsJune 2025
Registry record updatedApril 2, 2025
Trial IDNCT06836856 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with moderate to severe TBI, as indicated by a GCS score of 13 or lower, who have minimal associated injuries.

Probably not a fit

Patients with pre-existing bronchospastic conditions or those on beta-blocker therapy prior to injury may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of adjuvant beta blockers, specifically propranolol and carvedilol, on clinical outcomes in patients suffering from moderate to severe traumatic brain injury (TBI). The study aims to understand how the different receptor blockade profiles of these medications may influence secondary brain injury processes and overall patient recovery. Patients will be monitored for their responses to the treatments compared to a control group, with a focus on improving outcomes for those with TBI. The trial is designed to gather data that could lead to better therapeutic strategies for managing TBI.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery outcomes for patients with traumatic brain injury through the use of beta blockers.

How similar studies have gone: While the use of beta blockers in TBI is a novel approach, preliminary studies have suggested potential benefits, but further investigation is needed to confirm these findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\. Patients with moderate \& severe TBI detected on admission by CT scan and GCS score of ≤ 13 who either do not have any other injuries or only have associated minor injuries.

Minor injuries are defined as presence of any of the following:

1. Mild intraperitoneal free fluid (IPFF) observed through abdominal ultrasound.
2. mild lung contusion detected in the chest CT scan.
3. hemothorax or pneumothorax present without accompanying symptoms of hypoxia, tachypnea, or respiratory distress.
4. simple limb fractures.

Exclusion Criteria:

1. Patients on pre-injury beta-blocker therapy.
2. Patients with any bronchospastic conditions.
3. Patients with active acute coronary syndrome.
4. TBI with GCS ≤ 13 with associated major injuries defined as the presence of any of the following:

   1. Moderate \& marked IPFF requiring surgical intervention ( laparotomy ).
   2. moderate \& marked lung contusion, pneumothorax \& hemothorax with accompanying symptoms of hypoxia, tachypnea, lower limbs, or limb amputation.
   3. Compound fracture in the upper or lower limb.
   4. Open Faciomaxillary trauma.
5. Patients with persistent shock (systemic blood pressure \<100 mmHg, base deficit \> 4, or oliguria , HR \< 60 b/min ) after \> one week of admission.

Where it's running

  • Zagazig University Hospitals, Zagazig,
    Zagazig, Egypt
    Recruiting
  • Zagazig University Hospitals
    Zagazig, Egypt
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.